|国家科技期刊平台
首页|期刊导航|武警医学|京尼平苷对代谢综合征大鼠的干预作用及对脂肪因子的影响

京尼平苷对代谢综合征大鼠的干预作用及对脂肪因子的影响OACSTPCD

Effect of geniposide on metabolic syndrome rats and its influence on adipocytokines

中文摘要英文摘要

目的 探讨京尼平苷对高脂肪/高果糖饮食诱导代谢综合征(HFFD-MS)大鼠的干预作用及对脂肪因子的影响.方法 高脂肪/高果糖饮食持续 16 周,构建大鼠 HFFD-MS 模型,随机分为模型组、京尼平苷三个剂量组(分别按 30、60、120 mg/kg)、阳性对照组(二甲双胍 50 mg/kg);另取同期给予普通饲料和纯水饲养的大鼠为正常组,每组 10 只.灌胃给药8 周,计算脂体比及胰岛素抵抗模型评估指数(HOMA-IR),检测空腹血糖(FBG)及血清总胆固醇(TC)、三酰甘油(TG)、游离脂肪酸(FFA)及胰岛素(INS)水平,观察肾周脂肪细胞病理学改变,放射免疫法检测血清脂肪因子瘦素(LP)、内脂素(VIS)、脂联素(APN)、抵抗素(RES)、肿瘤坏死因子α(TNF-α)、白介素 6(IL-6)的表达水平.结果 与模型组相比,京尼平苷各剂量组肾周脂肪细胞体积更小,排列更紧密;且可明显降低HFFD-MS大鼠的体质量、内脏脂肪质量及脂体比,差异有统计学意义(P<0.05).另外,京尼平苷各剂量组可显著下调TC、TG、FFA、FBG、INS水平及HOMA-IR指数(P<0.01),可使血清LP、RES、TNF-α、IL-6水平明显降低(P<0.05),且京尼平苷高剂量组可显著上调APN的表达,差异有统计学意义(P<0.01),对VIS无显著性影响.结论 京尼平苷具有调控脂肪因子的异常分泌、减少内脏脂肪堆积、纠正糖脂代谢紊乱等作用,可明显改善HFFD-MS病理进程.

Objective To explore the effect of geniposide on high fat/high fructose diet-induced metabolic syndrome(HFFD-MS)and its influence on the adipocytokines.Methods HFFD-MS models of rats were induced by a 16-week high-fat/high-fructose di-et,and were randomly divided into model group,geniposide dose groups(30,60 and 120 mg/kg,respectively),and positive control(metformin 50 mg/kg)group,while the other rats fed with ordinary diet and pure water in the same period were divided into normal group with 10 rats in each group.After 8 weeks of intragastric administration,the fat-body ratio and insulin resistance(HOMA-IR)were calculated,fasting blood glucose(FBG),total cholesterol(TC),triglyceride(TG),free fatty acid(FFA),and insulin(INS)levels in serum were detected,and the pathologic changes were observed in perirenal adipocytes.The serum levels of adipocytokine leptin(LP),visfatin(VIS),adiponectin(APN),resistin(RES),tumor necrosis factor α(TNF-α)and interleukin 6(IL-6)were detected by radioimmunoassay.Results The perirenal adipocytes in geniposide dose groups were smaller and more tightly arranged than those in the model group.Compared with the model group,geniposide administration significantly reduced the body and visceral fat weights,and fat-body ratio in HFFD-MS rats(P<0.05),significantly down-regulated FBG,HOMA-IR and serum TC,TG,FFA and INS levels(P<0.01),significantly reduced serum LP,RES,TNF-α and IL-6 levels(P<0.05 or P<0.01),and the high-dose of geniposide evidently up-regulated the expression of APN(P<0.01).Geniposide administration had no significant effect on VIS.Conclusions Geniposide can obviously improve the pathological process of HFFD-MS by regulating the abnormal secretion of adipo-kines,reducing the accumulation of visceral fat and correcting the disorder of glucose-lipid metabolism.

骞秀芳;许长青;朱哲;李娟

100027,武警北京总队医院药剂科1000039 北京,解放军总医院第三医学中心泌尿外科

临床医学

京尼平苷代谢综合征大鼠高脂肪/高果糖脂肪因子

geniposidemetabolic syndromerathigh fat/high fructoseadipocytokine

《武警医学》 2024 (007)

553-557 / 5

评论